iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days; Zio XT System, a prescription-only remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and Zio ECG Utilization Software System, which supports the capture and analysis of ECG data. In addition, the company offers Zio AT System, a prescription-only remote ECG monitoring system, which consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days, as well as incorporates the Zio AT wireless gateway to provide connectivity between the patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. iRhythm Technologies, Inc. was incorporated in 2006 and is headquartered in San Francisco, California.

Period	TotalRevenue
2016-12-31	$64.07M
2017-12-31	$98.51M
2018-12-31	$147.28M
2019-12-31	$214.55M
2020-12-31	$265.17M
2021-12-31	$322.82M
2022-12-31	$410.92M
2023-12-31	$492.68M
2024-12-31	$591.84M

	A	B	C	D
1	Symbol	Price	Change	Volume
2	IRTC	$120.48	+1.56%	0.27M
3
4
5

iRhythm Technologies Inc. (IRTC) Revenue History

Revenue Data

Get iRhythm Technologies Inc. Data in Excel

More IRTC Financial Data